39456 Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices 

appearance in the preliminary phase of 

the investigation need not enter a 

separate appearance for the final phase 

of the investigation. Industrial users, 

and, if the merchandise under 

investigation is sold at the retail level, 

representative consumer organizations 

have the right to appear as parties in 

Commission antidumping and 

countervailing duty investigations. The 

Secretary will prepare a public service 

list containing the names and addresses 

of all persons, or their representatives, 

who are parties to the investigation. 

Background 

On June 28, 2017, The Timken 

Company, North Canton, Ohio, filed a 

petition with the Commission and 

Commerce, alleging that an industry in 

the United States is materially injured 

by reason of LTFV imports of tapered 

roller bearings from Korea. Accordingly, 

effective June 28, 2017, the Commission, 

pursuant to section 733(a) of the Act (19 

U.S.C. 1673b(a)), instituted antidumping 

duty investigation No. 731–TA–1380 

(Preliminary). 

Notice of the institution of the 

Commission’s investigation and of a 

public conference to be held in 

connection therewith was given by 

posting copies of the notice in the Office 

of the Secretary, U.S. International 

Trade Commission, Washington, DC, 

and by publishing the notice in the 

Federal Register of July 5, 2017 (82 FR 

31067). The conference was held in 

Washington, DC, on July 19, 2017, and 

all persons who requested the 

opportunity were permitted to appear in 

person or by counsel. 

The Commission made this 

determination pursuant to section 

733(a) of the Act (19 U.S.C. 1673b(a)). It 

completed and filed its determination in 

this investigation on August 14, 2017. 

The views of the Commission are 

contained in USITC Publication 4721 

(August 2017), entitled Tapered Roller 

Bearings from Korea: Investigation No. 

731–TA–1380 (Preliminary). 

By order of the Commission. 

Issued: August 14, 2017. 

William R. Bishop, 

Supervisory Hearings and Information 

Officer. 

[FR Doc. 2017–17467 Filed 8–17–17; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1005] 

Certain L-Tryptophan, L-Tryptophan 

Products, and Their Methods of 

Production: Notice of Request for 

Statements on the Public Interest 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the presiding administrative law judge 

has issued a Final Initial Determination 

and Recommended Determination on 

Remedy and Bonding in the abovecaptioned investigation. This notice is 

soliciting public interest comments from 

the public only. Parties are to file public 

interest submissions pursuant to 

Commission rules. 

FOR FURTHER INFORMATION CONTACT: 

Houda Morad, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW., 

Washington, DC 20436, telephone (202) 

708–4716. The public version of the 

complaint can be accessed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov, and will be 

available for inspection during official 

business hours (8:45 a.m. to 5:15 p.m.) 

in the Office of the Secretary, U.S. 

International Trade Commission, 500 E 

Street SW., Washington, DC 20436, 

telephone (202) 205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its Internet server (https://

www.usitc.gov). The public record for 

this investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. Hearingimpaired persons are advised that 

information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission is soliciting comments on 

public interest issues raised by the 

recommended relief, should the 

Commission find a violation, 

specifically: (1) A limited exclusion 

order (‘‘LEO’’) against certain Ltryptophan, L-tryptophan products, and 

their methods of production, which are 

imported, sold for importation, and/or 

sold after importation by Respondents 

CJ CheilJedang Corp. of Seoul, Republic 

of Korea, CJ America, Inc. (‘‘CJ 

America’’) of Downers Grove, Illinois, 

and PT CheilJedang Indonesia of Jakarta, 

Indonesia (collectively ‘‘CJ’’ or 

‘‘Respondents’’); and (2) a cease and 

desist order (‘‘CDO’’) against 

Respondent CJ America. 

Section 337 of the Tariff Act of 1930 

provides that if the Commission finds a 

violation it shall exclude the articles 

concerned from the United States: 

unless, after considering the effect of such 

exclusion upon the public health and 

welfare, competitive conditions in the United 

States economy, the production of like or 

directly competitive articles in the United 

States, and United States consumers, it finds 

that such articles should not be excluded 

from entry. 

19 U.S.C. 1337(d)(1). A similar 

provision applies to cease and desist 

orders. 19 U.S.C. 1337(f)(1). 

The Commission is interested in 

further development of the record on 

the public interest in these 

investigations. Accordingly, parties are 

to file public interest submissions 

pursuant to pursuant to 19 CFR 

210.50(a)(4). In addition, members of 

the public are hereby invited to file 

submissions of no more than five (5) 

pages, inclusive of attachments, 

concerning the public interest in light of 

the administrative law judge’s 

Recommended Determination on 

Remedy and Bonding issued in this 

investigation on August 11, 2017. 

Comments should address whether 

issuance of the LEO and CDO in this 

investigation, should the Commission 

find a violation, would affect the public 

health and welfare in the United States, 

competitive conditions in the United 

States economy, the production of like 

or directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the recommended 

orders are used in the United States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the recommended orders; 

(iii) identify like or directly 

competitive articles that complainants, 

their licensees, or third parties make in 

the United States which could replace 

the subject articles if they were to be 

excluded; 

(iv) indicate whether complainants, 

complainants’ licensees, and/or third 

party suppliers have the capacity to 

replace the volume of articles 

potentially subject to the recommended 

exclusion order and/or a cease and 

desist order within a commercially 

reasonable time; and 

(v) explain how the LEO and CDO 

would impact consumers in the United 

States. 

Written submissions from the public 

must be filed no later than by close of 

business on Wednesday, September 20, 

2017. 

mstockstill on DSK30JT082PROD with NOTICES

Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices 39457 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above and submit 8 true paper 

copies to the Office of the Secretary by 

noon the next day pursuant to section 

210.4(f) of the Commission’s Rules of 

Practice and Procedure (19 CFR 

210.4(f)). Submissions should refer to 

the investigation number (‘‘Inv. No. 

337–TA–1005’’) in a prominent place on 

the cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, https://www.usitc.gov/

secretary/fed_reg_notices/rules/

handbook_on_electronic_filing.pdf). 

Persons with questions regarding filing 

should contact the Secretary (202–205– 

2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. A redacted nonconfidential version of the document 

must also be filed simultaneously with 

any confidential filing. All nonconfidential written submissions will be 

available for public inspection at the 

Office of the Secretary and on EDIS. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of sections 201.10 and 210.50 of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.50). 

By order of the Commission. 

Issued: August 14, 2017. 

William R. Bishop, 

Supervisory Hearings and Information 

Officer. 

[FR Doc. 2017–17468 Filed 8–17–17; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–NEW] 

Agency Information Collection 

Activities; 

Proposed eCollection eComments 

Requested; DEA Ambassador Program 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-day Notice. 

SUMMARY: The Department of Justice 

(DOJ), Drug Enforcement 

Administration, will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. This proposed 

information collection was previously 

published in the Federal Register at 82 

FR 28355, on June 21, 2017, allowing for 

a 60-day comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

September 18, 2017. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Gary R. Owen, Chief, Office of 

Congressional & Public Affairs, Drug 

Enforcement Administration, 8701 

Morrissette Drive, Springfield, VA 

22152. Written comments and/or 

suggestions can also be sent to the 

Office of Management and Budget, 

Office of Information and Regulatory 

Affairs, Attention: Department of Justice 

Desk Officer, Washington, DC 20503 or 

sent to OIRA_submissions@

omb.eop.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Proposed collection. 

2. The Title of the Form/Collection: 

DEA Ambassador Program (DAP) 

Volunteer Application. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

The form number is DEA–320. The 

applicable component within the 

Department of Justice is the Drug 

Enforcement Administration. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Individuals. The 

Ambassador Program is designed to 

enhance the ability of the DEA Field 

Divisions to cultivate and leverage 

community relationships for the 

purpose of increasing illicit drug 

prevention and education strategies. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: It is estimated that 100 

respondents will complete the 

application in approximately 10 

minutes. 

6. An estimate of the total public 

burden (in hours) associated with the 

collection: The estimated public burden 

associated with this collection is 16.6 

hours. It is estimated that applicants 

will take 10 minutes to complete the 

DEA–320. The burden hours for 

collecting respondent data sum to 1,000 

hours (100 respondents × 10 minutes = 

1,000 hours). 1,000/60 seconds = 16.6. 

If additional information is required 

contact: Melody Braswell, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N street NE., 3E.405B, 

Washington, DC 20530. 

Dated: August 15, 2017. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2017–17469 Filed 8–17–17; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the Clean Air 

Act 

On August 14, 2017, the Department 

of Justice lodged a proposed Consent 

Decree (‘‘Consent Decree’’) with the 

United States District Court for the 

District of Connecticut in the lawsuit 

entitled United States v. City of 

Waterbury, CT and Synagro Northeast, 

LLC, Civil Action No. 2:17–cv–01377. 

In a Complaint, the United States, on 

behalf of the U.S. Environmental 

Protection Agency (‘‘EPA’’), alleges that 

mstockstill on DSK30JT082PROD with NOTICES